• Wyoming marks the 23rd state where Syra Health has active contracts

CARMEL, Ind., July 30, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it has been awarded a population health contract by the Wyoming Department of Health, Behavioral Health Division. This marks Syra Health's entry into its 23^rd state, further expanding its presence and reinforcing its commitment to improving population health nationwide.

The contract, awarded under the Bipartisan Safer Communities Act (BSCA) Grant, aims for Syra Health to conduct a comprehensive situational assessment of the emergency preparedness plans for eight Wyoming Behavioral Health Centers (BHCs). The evaluation will encompass a SWOT analysis for each plan, identifying strengths, weaknesses, opportunities, and threats. Based on the findings, Syra Health will recommend tailored improvements to address identified gaps, enhance mental health services after traumatic events, and suggest relevant training opportunities to better prepare the BHCs for effective responses.

Syra Health's Population Health Management team includes data analysts, public health, and subject matter experts who will oversee and execute the project. Progress updates will detail team efficiency in the deliverables.

"This project exemplifies our dedication to improving community well-being and healthcare readiness across the nation," said Dr. Deepika Vuppalanchi, CEO, Syra Health. "By integrating our expertise in mental and behavioral health, with our proficiency in capacity planning and project management, we will deliver significant improvements."

ABOUT SYRA HEALTH

Syra Health is a healthcare technology company powering better health in challenging areas such as behavioral and mental health, digital health, and population health, by providing innovative services and technology products. Syra Health's offerings are centered on prevention, improved access, and affordable care. Syra Health supplies its solutions to payers, providers, life sciences organizations, academic institutions, and the government. For more information, please visit www.syrahealth.com.

FORWARD-LOOKING STATEMENTS

Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2023, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contacts

For Media Inquiries:

Christine Drury

Communications and Marketing Director

Syra Health

463-345-5180

This email address is being protected from spambots. You need JavaScript enabled to view it.

For Investor Inquiries:

Ben Shamsian

Vice President

Lytham Partners, LLC

646-829-9701

This email address is being protected from spambots. You need JavaScript enabled to view it.